https://www.selleckchem.com/pr....oducts/monocrotaline
6%, UR 56.8%, BPS/IC 63.15%, FI 87.5% and DI 66.7%. Clinical and/or statistically significant improvements in all efficacy variables studied were observed. The loss of therapeutic effect at 75 months follow-up was 34%. Device-related pain appeared in 25 patients (39%), 20 resolved by reprogramming and 5 required device removal. An overall improvement in QoL and high levels of satisfaction with the procedure were observed. More than 90% of patients would recommend SNS to a friend or relative. SNS is a minimally invasive procedure t
Synes godt om
Kommentar
Del
